Stanford University experts call their new neural network “LungNet” and say the system has delivered consistent, fast and accurate interpretation of computed tomography scans.

Deep01 said the lion’s share of the contribution comes by way of electronics manufacturer Asus, with other Taiwan-based firms such as BE Capital also contributing. 

London investment firm MMC Ventures is pitching in the largest share of capital, with additional contributions from Bayer, Seedcamp and InHealth Ventures, Agamon announced Monday. 

The National Cancer Institute model only accounts for colon and breast cancer screenings and represents a roughly 1% increase over pre-COVID-19 estimates. 

Barcelona health tech investment firm Nina Capital and Oxford Sciences Innovation also contributed during this round of funding, Ultromics announced. 

Vara recently announced the new capital contribution, with the venture investment arm of the Ontario Municipal Employees Retirement System pitching in the largest share.

In magnetic resonance alone, the Chicago-based corporation estimated that U.S. providers have postponed upward of 5 million scans since the pandemic started. 

Australia-based 4DMedical said the software can also assist in assessing patients with asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung cancer. 

Johns Hopkins has scored a $195,000 grant from the National Science Foundation, with its scientists now beginning the first phase of the one-year research project.

That’s according to the results of a new investigation, led by University of Cambridge experts and published 
in the Proceedings of the National Academy of Sciences. 
 

San Francisco-based Braid Health, which creates artificial intelligence tools for rads, just announced its latest cash infusion. 

Case Western Reserve University said its new AI tool could make it easier to triage patients and deploy scarce resources during the pandemic.